This retrospective case series study examines immune response of adults with hematologic malignant disease who were vaccinated with 1 of 3 FDA-authorized COVID-19 vaccines between February and April of 2021.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8358793 | PMC |
http://dx.doi.org/10.1001/jamaoncol.2021.4381 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!